Liver cancer vaccine effective in mice
6/05/2014

Tweaking a protein expressed by most liver cancer cells has enabled scientists to make a vaccine that is exceedingly effective at preventing the disease in mice.

Study shows Zykadia™ shrank tumors in the majority of patients with ALK+ NSCLC, regardless of prior ALK treatment
6/05/2014

Novartis has announced data showing Zykadia™ (ceritinib, previously known as LDK378) shrank tumors in patients with anaplastic lymphoma kinase-positive (ALK+) non-small cell lung cancer...

Pivotal Phase III data show polycythemia vera patients on Jakavi® achieved significant improvement in disease control
6/05/2014

Novartis has announced results from the first-ever pivotal Phase III study evaluating a JAK 1/2 inhibitor for the treatment of polycythemia vera (PV).

Half a million cancers prevented by colorectal cancer screening
6/05/2014

An estimated half a million cancers were prevented by colorectal cancer screening in the United States from 1976 to 2009, report researchers from the Cancer Outcomes, Public Policy, and Effectiveness...

The most aggressive cancer cells isolated by new device
6/05/2014

Not all cancer cells are created equal - some stay put in the primary tumor, while others move and invade elsewhere.

New device "NIRFLI" may enable earlier detection and better management of cancer therapy and lymphedema
6/05/2014

The human lymphatic system is an important but poorly understood circulatory system consisting of tiny vessels spread throughout the body.

For the first time tumor chromosomal translocations reproduced in human cells
6/05/2014

Scientists from the Spanish National Cancer Research Centre (CNIO) and the Spanish National Cardiovascular Research Centre (CNIC) have been able to reproduce, for the first time in human cells...

Predicting breast cancer metastatic risk
6/05/2014

The study was led by researchers at the National Cancer Institute (NCI)-designated Albert Einstein Cancer Center of Albert Einstein College of Medicine of Yeshiva University and Montefiore Einstein...

Promising long-term results for combination immunotherapy for advanced melanoma
6/05/2014

The first long-term follow-up results from a phase 1b immunotherapy trial combining drugs for advanced melanoma patients has shown encouraging results - long-lasting with high survival rates ...

Public health often ignored in transportation policy: major roads built in poorest neighborhoods
6/05/2014

A new study from the University of Colorado Denver shows public health issues are often ignored in many transportation projects, especially when major roads are built through lower-income...